Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.50 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.50 |
| ▸ | PRSS2 | P07478 | 2/20 | 0.50 |
| ▸ | PRSS3 | P35030 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | CA3 | P07451 | 1/20 | 0.45 |
| ▸ | CA6 | P23280 | 1/20 | 0.45 |
| ▸ | CA5A | P35218 | 1/20 | 0.45 |
| ▸ | CA7 | P43166 | 1/20 | 0.45 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22302 | 0.81 | F2 (0.52) | F2PRSS1PRSS2PRSS3GAA | |
| SCHEMBL25376416 | 0.79 | F2 (0.50) | F2PRSS1PRSS2PRSS3CA1 | |
| SCHEMBL26037514 | 0.79 | F2 (0.50) | F2PRSS1PRSS2PRSS3GAA | |
| SCHEMBL6416400 | 0.78 | KEAP1 (0.44) | HTTLMNADDAH1CA12CA1 | |
| SCHEMBL484742 | 0.78 | CA1 (0.63) | LMNACYP2C19CA1CA2CA9 | |
| SCHEMBL28209363 | 0.78 | F2 (0.48) | F2PRSS1PRSS2PRSS3GAA | |
| SCHEMBL5950368 | 0.78 | F2 (0.48) | F2PRSS1PRSS2PRSS3GAA | |
| SCHEMBL2412815 | 0.76 | F2 (0.55) | F2PRSS1PRSS2PRSS3GAA | |
| SCHEMBL5138891 | 0.75 | F2 (0.59) | F2PRSS1PRSS2PRSS3GAA | |
| SCHEMBL10884771 | 0.75 | F2 (0.46) | F2PRSS1PRSS2PRSS3GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114746543-A | Method for isolating pure cultured vascular endothelial cells, medium for maintaining characteristics of vascular endothelial cells, and culture method comprising same | 延世大学校产学协力团 | 2022-07-12 | — | — | CN | claimed |
| CN-108877975-B | Neutron shielding protective material | 湘潭大学 | 2022-03-22 | — | — | CN | claimed |
| CN-111521667-B | Method for detecting rare earth elements in magnetite | 中国科学院地质与地球物理研究所 | 2020-11-20 | — | — | CN | claimed |
| CN-111413189-B | Method for detecting trace elements in pyrite | 中国科学院地质与地球物理研究所 | 2020-10-20 | — | — | CN | claimed |
| CN-111521667-A | Method for detecting rare earth elements in magnetite | 中国科学院地质与地球物理研究所 | 2020-08-11 | — | — | CN | claimed |
| CN-111413189-A | Method for detecting trace elements in pyrite | 中国科学院地质与地球物理研究所 | 2020-07-14 | — | — | CN | claimed |
| CN-101735127-A | Method for preparing tosyl isothiocyanate | WEST BRANCH OF ZHEJIANG UNIVER | 2010-06-16 | — | — | CN | claimed |
| US-12637697-B2 | Compositions and methods for generating physiological X chromosome inactivation | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2026-05-26 | — | — | US | disclosed |
| EP-4719052-A1 | GENETICALLY MODIFIED PORCINE CELL, GENETICALLY MODIFIED PIG AND METHODS OF PRODUCING SAME | Wolf, Eckhard (DE) | 2026-04-08 | — | — | EP | disclosed |
| EP-4626483-A1 | SURFACE MODIFIED CARBON NANOTUBES AND USES THEREOF | Luna Labs USA, LLC (US) | 2025-10-08 | — | — | EP | disclosed |
| US-20250185233-A1 | SEMICONDUCTOR DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-06-05 | — | — | US | disclosed |
| CN-119968417-A | Bovine blastocyst-like structure and application thereof | 路易斯安娜州立大学监测委员会，农业和机械学院 | 2025-05-09 | — | — | CN | disclosed |
| CN-119790143-A | Materials and methods for bioengineering iPSC populations | 詹森生物科技公司 | 2025-04-08 | — | — | CN | disclosed |
| EP-0819118-B1 | POTASSIUM ION CHANNEL BLOCKERS | POLYCHIP PHARMACEUTICALS PTY (AU) | 2002-09-18 | — | — | EP | disclosed |
| WO-2001087863-A1 | 3-ARYLISOTHIAZOLES AND THEIR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2001-11-22 | — | — | WO | disclosed |
| US-5929082-A | SULFONYL(THIO)UREA AND SULFONYLGUANIDINE COMPOUNDS; TREATMENT OF DIABETES, CARDIAC ARRHYTHMIAS, ISCHEMIA, HYPOXIC CARDIOVASCUALR DISORDERS AND CANCER | POLYCHIP PHARMACEUTICALS PTY LTD (AU) | 1999-07-27 | — | — | US | disclosed |
| EP-0819118-A4 | POTASSIUM ION CHANNEL BLOCKERS | POLYCHIP PHARMACEUTICALS PTY (AU) | 1998-04-29 | — | — | EP | disclosed |
| EP-0819118-A1 | POTASSIUM ION CHANNEL BLOCKERS | Polychip Pharmaceuticals Pty. Ltd. (AU) | 1998-01-21 | — | — | EP | disclosed |
| WO-1996030341-A1 | POTASSIUM ION CHANNEL BLOCKERS | POLYCHIP PHARMACEUTICALS PTY. LTD. (AU) | 1996-10-03 | — | — | WO | disclosed |
| US-4288454-A | Antiviral 1-adamantyl-3-(phenylsulfonyl)thioureas | HOFFMAN-LA ROCHE INC. (US) | 1981-09-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12637697-B2 | Compositions and methods for generating physiological X chromosome inactivation | KDM6B, KDM1B, KDM6A | F2 4624/4885PRSS1 3097/4885PRSS2 2624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.